128 related articles for article (PubMed ID: 38358905)
1. In vitro differential inhibition of the factor XI activity assay in the setting of a lupus anticoagulant.
Rabichow L; Dinh J; Nguyen L; Qiao J
Blood Coagul Fibrinolysis; 2024 Jun; 35(4):217-222. PubMed ID: 38358905
[TBL] [Abstract][Full Text] [Related]
2. Activated partial thromboplastin time derivative curves: helpful diagnostic tool in mixing test interpretation.
Esmedere Eren S; Karakukcu C; Ciraci MZ; Ustundag Y; Karakukcu M
Blood Coagul Fibrinolysis; 2018 Jun; 29(4):410-414. PubMed ID: 29708898
[TBL] [Abstract][Full Text] [Related]
3. How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors.
Favaloro EJ; Kershaw G; Mohammed S; Lippi G
Semin Thromb Hemost; 2019 Feb; 45(1):22-35. PubMed ID: 30630206
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies.
Lawrie AS; Kitchen S; Purdy G; Mackie IJ; Preston FE; Machin SJ
Clin Lab Haematol; 1998 Jun; 20(3):179-86. PubMed ID: 9681235
[TBL] [Abstract][Full Text] [Related]
5. Transfusion-induced specific anti-factor XI inhibitor in a patient with previously unrecognized factor XI deficiency.
Musclow CE; Amato D; Ofosu F; Armstrong AL; Abbott D
Am J Clin Pathol; 1988 Mar; 89(3):418-22. PubMed ID: 3258118
[TBL] [Abstract][Full Text] [Related]
6. Acquired factor XI inhibitors in congenitally deficient patients.
Schnall SF; Duffy TP; Clyne LP
Am J Hematol; 1987 Dec; 26(4):323-8. PubMed ID: 3687930
[TBL] [Abstract][Full Text] [Related]
7. [Lupus anticoagulant-hypoprothrombinemia syndrome with a false-positive test for coagulation factor inhibitors].
Morinaga S; Ide Y; Kusumoto M; Ogata M; Takaki K; Matsumoto E
Rinsho Ketsueki; 2012 Jul; 53(7):716-20. PubMed ID: 22975775
[TBL] [Abstract][Full Text] [Related]
8. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
9. Prolonged Activated Partial Thromboplastin Time: Difficulties in Discriminating Coexistent Factor VIII Inhibitor and Lupus Anticoagulant.
Ames PR; Graf M; Archer J; Scarpato N; Iannaccone L
Clin Appl Thromb Hemost; 2015 Mar; 21(2):149-54. PubMed ID: 24989713
[TBL] [Abstract][Full Text] [Related]
10. Paired APTTs of low and high lupus anticoagulant sensitivity permit distinction from other abnormalities and achieve good lupus anticoagulant detection rates in conjunction with dRVVT.
Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
Int J Lab Hematol; 2019 Feb; 41(1):60-68. PubMed ID: 30248243
[TBL] [Abstract][Full Text] [Related]
11. Studies on a circulating anticoagulant inhibiting factor XI in a patient with congenital deficiency and carcinoma of the prostate.
Chediak J; Madej-Zevin P; Ratnoff OD; Goldsmith GH; Everson B
Br J Haematol; 1986 May; 63(1):123-33. PubMed ID: 3486671
[TBL] [Abstract][Full Text] [Related]
12. Successful childbirth by a patient with congenital factor XI deficiency and an acquired inhibitor.
Ginsberg SS; Clyne LP; McPhedran P; Duffy TP; Hanson T
Br J Haematol; 1993 May; 84(1):172-4. PubMed ID: 8338772
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic difficulties of factor XI deficiencies: interferences' assay or real deficit?
Gaymard A; Nougier C
Ann Biol Clin (Paris); 2016 Jun; 74(3):341-7. PubMed ID: 27112703
[TBL] [Abstract][Full Text] [Related]
14. Interference from lupus anticoagulant on von Willebrand factor measurement in splenic marginal zone lymphoma: a case report.
Vinholt PJ; Nybo M
Blood Coagul Fibrinolysis; 2015 Jun; 26(4):454-7. PubMed ID: 25485787
[TBL] [Abstract][Full Text] [Related]
15. An Easy Method to Eliminate the Effect of Lupus Anticoagulants in the Coagulation Factor Assay.
Tang N; Yin S
Clin Lab; 2016 Jul; 62(7):1363-1365. PubMed ID: 28164630
[TBL] [Abstract][Full Text] [Related]
16. Effect of lupus anticoagulants on the activated partial thromboplastin time. Results of the College of American Pathologists survey program.
Brandt JT; Triplett DA; Rock WA; Bovill EG; Arkin CF
Arch Pathol Lab Med; 1991 Feb; 115(2):109-14. PubMed ID: 1899555
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of several laboratory tests and test combinations in the detection of lupus anticoagulant.
Legnani C; Palareti G; Boggian O; Cavallaroni K; Oca G; Lo Manto G; Abate C; Coccheri S
Int J Clin Lab Res; 1992; 22(2):106-10. PubMed ID: 1504302
[TBL] [Abstract][Full Text] [Related]
18. [Lupus anticoagulant screening: comparison of 5 tests (author's transl)].
Follea G; Ffrench P; Trzeciak MC; Dechavanne M
Nouv Rev Fr Hematol (1978); 1981; 23(4):203-7. PubMed ID: 7312614
[TBL] [Abstract][Full Text] [Related]
19. The dilute phospholipid APTT: a sensitive assay for verification of lupus anticoagulants.
Alving BM; Baldwin PE; Richards RL; Jackson BJ
Thromb Haemost; 1985 Oct; 54(3):709-12. PubMed ID: 3937268
[TBL] [Abstract][Full Text] [Related]
20. Acquired factor XI inhibitors in two patients with hereditary factor XI deficiency.
Morgan K; Schiffman S; Feinstein D
Thromb Haemost; 1984 Jul; 51(3):371-5. PubMed ID: 6333735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
